AXIM - AXIM Biotechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue47.05949.139-
Cost of Revenue154.1350.387-
Gross Profit-107.071-1.248-
Operating Expenses
Research Development235.579571.455571.455
Selling General and Administrative3,413.4569,475.724505.729
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-3,759.462-10,049.546-505.729
Income from Continuing Operations
Total Other Income/Expenses Net-1,774.71-1,774.71-1,774.71
Earnings Before Interest and Taxes-5,534.172-10,049.546-505.729
Interest Expense275.73443.22132.522
Income Before Tax-5,809.906-10,092.767-538.251
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-5,809.906-10,092.767-538.251
Non-recurring Events
Discontinued Operations---44.696
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-5,809.906-10,092.767-582.947
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,284.906-10,092.767-582.947